Agios Pharmaceuticals AGIO
NASDAQ AGIO
$31.92 -0.56 (-1.71%)
As of: Oct 2, 2026 · 3:08 PM EDT

Agios Pharmaceuticals (AGIO) Return on Assets [ROA] (2013 - 2026)

Updated

Agios Pharmaceuticals' Return on Assets [ROA] was -37.68% in Q2 2026, down 78.49 percentage points from 40.82% a year earlier and down 1.54 percentage points from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) Return on Assets [ROA] (2013 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Agios Pharmaceuticals came in at -27.89%, down 79.71 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of +9.66 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was 51.82% in FY2024 (+84.18 pp), -32.36% in FY2023 (-15.04 pp), -17.32% in FY2022 (-157.43 pp) and 140.11% in FY2021 (+177.66 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q2 2024.
  • Compared with a year earlier, Return on Assets [ROA] has declined for four straight quarters, with an average year-over-year change of +1.10 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2021 (a gain of 144.90 percentage points); the worst was Q4 2022 (a drop of 126.89 percentage points).
  • Per Business Quant data, AGIO's Return on Assets [ROA] in the three quarters before Q2 2026 was -36.14% (Q1 2026), -33.18% (Q4 2025) and -30.36% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Agios Pharmaceuticals 1.98 Bn 1.98 Bn 41.75 Mn -37.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.68%
Mar 31, 2026 -36.14%
Dec 31, 2025 -33.18%
Sep 30, 2025 -30.36%
Jun 30, 2025 40.82%
Mar 31, 2025 39.70%
Dec 31, 2024 37.83%
Sep 30, 2024 51.00%
Jun 30, 2024 -47.47%
Mar 31, 2024 -40.83%
Dec 31, 2023 -36.54%
Sep 30, 2023 -21.29%
Jun 30, 2023 -19.06%
Mar 31, 2023 -18.37%
Dec 31, 2022 -19.16%
Sep 30, 2022 -29.84%
Jun 30, 2022 -28.59%
Mar 31, 2022 -26.28%
Dec 31, 2021 107.73%
Sep 30, 2021 93.77%
API Access

Agios Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AGIO&period=max&api_key=YOUR_API_KEY